Targeting mulitple dyslipidemias with fixed combinations – focus on extended release niacin and simvastatin

Dyslipidemia is a major risk factor in the initiation and progression of cardiovascular diseases such as atherosclerosis. Several pharmacological agents have been developed over the past 50 years which target various lipid components such as low density lipoprotein (LDL) cholesterol, triglyceride, a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pandian, Anbu, Arora, Anjali, Sperling, Laurence S, Khan, Bobby V
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2008
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2605342/
https://ncbi.nlm.nih.gov/pubmed/19183748
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky